
Why This Chinese Herbal Medicine Stock Backed by BlackRock and Morgan Stanley Gained 50,000% in 6 Months Despite Posting ...
Shares of Regencell Bioscience (NASDAQ:RGC) gained 49,637% in the past six months despite record losses since going public in 2021. The Chinese medicine company, with shareholders like Digital Mobile Venture, BlackRock, Morgan Stanley, and RBC, went public …